Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Genocea Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - GNCA



NEW YORK, Dec. 16, 2017 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Genocea Biosciences, Inc. ("Genocea" or the "Company") (NASDAQ:  GNCA) and certain of its officers.   The class action, filed in United States District Court, for the District of Massachusetts, and docketed under 17-cv-12168, is on behalf of a class consisting of investors who purchased or otherwise acquired Genocea securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Genocea securities between May 5, 2017, and September 25, 2017, both dates inclusive, you have until January 2, 2018 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

Genocea is a biopharmaceutical company that discovers and develops vaccines and immunotherapies.  At all relevant times, Genocea's genital herpes immunotherapy product GEN-003 was the Company's lead product candidate.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:  (i) the Company's finances were insufficient to support Phase 3 trials of GEN-003; (ii) accordingly, Genocea had overstated the prospects for GEN-003; and (iii) as a result of the foregoing, Genocea's public statements were materially false and misleading at all relevant times.   

On September 25, 2017, post-market, Genocea disclosed that it was halting spending and activities on GEN-003 and exploring strategic alternatives for the drug. The Company also announced that it was cutting 40% of its workforce.

On this news, the Company's share price fell $4.08, or 76.5%, to close at $1.25 on September 26, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

SOURCE Pomerantz LLP


These press releases may also interest you

at 14:30
UFCW Locals 1776 and 23 today thanked Governor Wolf for his plan that would update Pennsylvania's overtime rules, which have not changed in more than 40 years. "This is an important step to take in strengthening the middle class in Pennsylvania,"...

at 14:30
Following a disciplinary hearing held on November 15, 2017 in Montreal, Quebec, a Hearing Panel of the Investment Industry Regulatory Organization of Canada (IIROC) found that Jean?Louis Trudeau engaged in discretionary trading in a client's...

at 14:23
The following issues have been halted by IIROC: Company: North Bluff Capital Corp. TSX-Venture Symbol: NBK.H Reason: At the Request of the Company Pending News Halt Time (ET): 14:17 IIROC can make a decision to impose a temporary suspension...

at 14:04
Elemental Energy Inc. ("Elemental") announced the completion of the 17 megawatt ("MW") Brooks Solar project located in Newell County, Alberta. The project has achieved commercial operation and is now feeding renewable energy into the Alberta grid....

at 14:03
After almost 18 years as head of World Education Services' Canadian Office, Tim Owen announced his retirement, effective in May of 2018. Owen will continue to serve as Director of WES Canada and Deputy Director of World Education Services (WES) until...

at 14:03
Partners Real Estate Investment Trust ("Partners REIT") is pleased to announce a $0.02083 per Unit distribution for January 2018. The distribution will be paid on February 15, 2018 to unitholders of record as at January 31, 2018. Partners REIT...




News published on 16 december 2017 at 20:00 and distributed by: